Why increase dialysate sodium concentration in patients with hypotension during hemodialysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Why Increase Dialysate Sodium During Hemodialysis-Related Hypotension

Increasing dialysate sodium concentration to 148 mEq/L during hypotensive episodes provides immediate hemodynamic support by maintaining plasma volume and vascular refill rate, preventing further blood pressure decline during ultrafiltration. 1

Physiological Mechanism

The rationale for higher dialysate sodium centers on preventing intravascular volume depletion during fluid removal:

  • Higher dialysate sodium (148 mEq/L) maintains plasma osmolality, which sustains the osmotic gradient needed for plasma refilling from the interstitial space as ultrafiltration removes fluid from the vascular compartment 1
  • Sodium profiling (starting at 145-155 mEq/L and decreasing to 135-140 mEq/L) provides early hemodynamic stability when ultrafiltration rates are highest, then reduces sodium loading later in the session 1, 2
  • The mechanism works by preventing the rapid decline in plasma osmolality that would otherwise impair fluid movement from tissues into blood vessels, leading to inadequate cardiac filling and hypotension 3

Clinical Application Strategy

For acute hypotension during dialysis:

  • Increase dialysate sodium to 148 mEq/L immediately, particularly in the first half of treatment when ultrafiltration rates are typically highest 1, 2
  • This intervention is most effective when combined with reducing or temporarily stopping ultrafiltration 2

For patients with recurrent hypotension:

  • Implement sodium profiling with higher concentrations (145-155 mEq/L) early in treatment, followed by stepwise or continuous decrease to lower values (135-140 mEq/L) 1, 2
  • Consider switching from acetate-based to bicarbonate-based dialysate, as acetate inappropriately decreases vascular resistance and worsens hypotension 1, 2

Critical Caveats and Trade-offs

The major limitation is that higher dialysate sodium creates a vicious cycle:

  • Increased sodium loading stimulates thirst and increases interdialytic fluid gain 1, 4, 5
  • Greater fluid accumulation necessitates higher ultrafiltration rates at subsequent sessions, paradoxically increasing hypotension risk 5, 3
  • Long-term use of high dialysate sodium (≥140 mEq/L) aggravates hypertension and cardiovascular workload 1, 4

Recent high-quality evidence reveals important nuances:

  • A 2024 randomized trial found that raising dialysate sodium from 135 to 140 mEq/L reduced intradialytic hypotension (OR 0.66) but caused marked increases in blood pressure (7.0/3.9 mmHg) and interdialytic weight gain 6
  • The same study showed lowering sodium from 138 to 135 mEq/L increased dialysis symptoms despite reducing weight gain, with no effect on hypotension rates 6

Balancing Short-term vs Long-term Outcomes

For hemodynamically unstable patients requiring immediate intervention, higher dialysate sodium (148 mEq/L) is justified as it provides acute hemodynamic benefits that prevent premature dialysis termination and inadequate solute clearance 1, 5

However, the long-term strategy should prioritize:

  • Extending dialysis treatment duration to reduce hourly ultrafiltration rates, which addresses the root cause of hypotension 1, 2
  • Strict dietary sodium restriction between sessions to minimize interdialytic weight gain 1, 4
  • Targeting lower maintenance dialysate sodium (135-138 mEq/L) once hemodynamic stability is achieved 1, 4

Alternative Concurrent Strategies

To minimize reliance on high dialysate sodium:

  • Reduce dialysate temperature to 34-35°C, which increases peripheral vasoconstriction and cardiac output through enhanced sympathetic tone, reducing hypotension incidence from 44% to 34% 1, 2
  • Administer midodrine (α1-adrenergic agonist) within 30 minutes before dialysis to increase peripheral vascular resistance 1, 2, 7
  • Raise hemoglobin to 11 g/dL to improve oxygen-carrying capacity and reduce hypotension frequency 1, 2
  • Avoid food intake immediately before or during dialysis, as eating decreases peripheral vascular resistance 1, 2

Practical Algorithm

For acute hypotension (systolic BP drop >20 mmHg with symptoms):

  1. Stop or reduce ultrafiltration immediately 2
  2. Increase dialysate sodium to 148 mEq/L 1, 2
  3. Place patient in Trendelenburg position 2
  4. Administer normal saline bolus if needed 2

For prevention in hypotension-prone patients:

  1. Implement sodium profiling (145-155 mEq/L decreasing to 135-140 mEq/L) 1, 2
  2. Extend treatment time to reduce ultrafiltration rate below 10 mL/kg/hour 1, 2
  3. Lower dialysate temperature to 35°C 1, 2
  4. Consider midodrine 30 minutes pre-dialysis 1, 2

Long-term management:

  1. Enforce dietary sodium restriction to reduce interdialytic weight gain 1, 4
  2. Gradually reduce maintenance dialysate sodium toward 135-138 mEq/L as tolerated 1, 4
  3. Avoid sustained use of dialysate sodium ≥140 mEq/L due to cardiovascular risks 1, 4, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Hypotension During Hemodialysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pathophysiology of dialysis hypotension: an update.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001

Guideline

Dialysate Sodium Management for ESRD Patients with Severe Hyponatremia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Dialysate sodium and intradialytic hypotension.

Seminars in dialysis, 2017

Research

Dialysate Sodium Lowering in Maintenance Hemodialysis: A Randomized Clinical Trial.

Clinical journal of the American Society of Nephrology : CJASN, 2024

Guideline

Management of Muscle Cramps Post-Hemodialysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.